
Build Your Quality Management System
Build a lean, scalable QMS to comply with ISO 13485, MDSAP, FDA, and MDR requirements, with personalized guidance from quality experts every step of the way
Validate your product through facilitated usability testing and "assumption audits" with Rellia's clinician network. Gain the IRB guidance and professional feedback needed to bridge the gap between prototype and clinical use.

By the end of this program, you will have real clinical feedback and a validation framework investors trust.
Structured usability feedback from matched clinical end-users
IRB-compliant research methodology and documentation
Validated product-market fit with clinician-generated evidence
Actionable product improvement recommendations based on real workflow testing
Investor-ready clinical validation summary
Connect with real clinicians, run structured feedback sessions, and produce evidence that matters to investors and buyers.
Connect with vetted clinicians, nurses, and healthcare professionals from Rellia's network who match your product's clinical use case for structured feedback sessions.
Run facilitated usability sessions with real clinical end-users, guided by research methodology that produces actionable, publishable insights.
Navigate IRB requirements and ethical considerations for clinical feedback so your evidence is credible and your process is compliant.
Clinical Validation
Move from assumptions to evidence with structured clinical feedback that investors and buyers trust.
User-Centered Design
Identify workflow gaps and usability barriers before you scale — saving months of rework.
Compliant Process
Follow a research process that meets ethical standards and can support future regulatory submissions.
Publishable Insights
Generate findings structured enough to inform white papers, case studies, or clinical validation plans.
8 weeks from prototype to validated clinical feedback
Join the waitlist to be notified when First 50 Users opens for the next cohort.
Join the waitlist and we'll notify you when the next cohort begins.